secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELI LILLY & Co (LLY)
CIK:        0000059478
Form:       8-K
Filed at:   2024-07-10T23:59:59+00:00
Accession:  0000059478-24-000164
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Eli Lilly CFO Anat Ashkenazi resigns; Gordon Brooks interim CFO from July 15
----------------------------------------------------------------------------

- Anat Ashkenazi resigned as EVP and CFO to pursue opportunity outside pharma; stays through July for transition.
- Gordon Brooks, group VP controller and corporate strategy, named interim CFO effective July 15, 2024.
- Brooks has 29-year Lilly career including CFO of U.S. Bio-Medicines and chief procurement officer.
- No arrangements or family relationships; selection not pursuant to any agreement with outsiders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/59478/000005947824000164/0000059478-24-000164-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/59478/000005947824000164/lly-20240705.htm
  HTML page:      https://secwatch.observer/filing/0000059478-24-000164

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer